Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases

Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases

Vaccines can prevent many millions of illnesses against infectious diseases and save numerous lives every year. However, traditional vaccines such as inactivated viral and live attenuated vaccines cannot adapt to emerging pandemics due to their time-consuming development. With the global outbreak of...

Full description

Bibliographic Details
Main Authors:	Lu Yang, Lin Tang, Ming Zhang, Chaoyong Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	mRNA vaccine infectious diseases COVID-19 mRNA structure design mRNA delivery
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.896958/full

Similar Items

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
by: Min Tang, et al.
Published: (2023-04-01)

Advancing mRNA technologies for therapies and vaccines: An African context
by: Dylan Kairuz, et al.
Published: (2022-10-01)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
by: Yusi Wang, et al.
Published: (2022-02-01)

mRNA vaccines in the prevention and treatment of diseases
by: Yangzhuo Gu, et al.
Published: (2022-09-01)

Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
by: Magdalena M. Żak, et al.
Published: (2023-08-01)

Advances in mRNA Vaccines for Infectious Diseases
by: Cuiling Zhang, et al.
Published: (2019-03-01)

mRNA therapeutics: New vaccination and beyond
by: Huan-Huan Wei, et al.
Published: (2023-09-01)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
by: Reese Jalal Ladak, et al.
Published: (2022-05-01)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)

Development and Delivery Systems of mRNA Vaccines
by: Yongjun Liang, et al.
Published: (2021-07-01)

Corrigendum: Development and Delivery Systems of mRNA Vaccines
by: Yongjun Liang, et al.
Published: (2021-09-01)

mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
by: Albert Liu, et al.
Published: (2022-07-01)

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
by: Yu-Shiuan Wang, et al.
Published: (2023-10-01)

Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
by: Xueliang Yu, et al.
Published: (2021-11-01)

Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity
by: Denise A Warzak, et al.
Published: (2023-10-01)

Ionizable Lipid Nanoparticles for mRNA Delivery
by: Xuefeng Tang, et al.
Published: (2023-08-01)

mRNA cancer vaccines: Advances, trends and challenges
by: Qing He, et al.
Published: (2022-07-01)

How mRNA therapeutics are entering the monoclonal antibody field
by: Lien Van Hoecke, et al.
Published: (2019-02-01)

Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
by: Magdalena M. Żak, et al.
Published: (2021-10-01)

mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
by: Shuqin Xu, et al.
Published: (2020-09-01)

Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA
by: Lea Andrée, et al.
Published: (2022-09-01)

Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
by: Yuan Yuan, et al.
Published: (2023-01-01)

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
by: Md. Motiar Rahman, et al.
Published: (2021-03-01)

mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions
by: Kaiting Xiao, et al.
Published: (2024-01-01)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
by: Chiranjib Chakraborty, et al.
Published: (2021-07-01)

The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
by: Karol Kurpiejewski, et al.
Published: (2024-02-01)

In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
by: Ignasi Esteban, et al.
Published: (2021-03-01)

mRNA vaccine: a potential therapeutic strategy
by: Yang Wang, et al.
Published: (2021-02-01)

Poly(ethylene Glycol) (PEG)–OligoRNA Hybridization to mRNA Enables Fine‐Tuned Polyplex PEGylation for Spleen‐Targeted mRNA Delivery
by: Miki Suzuki, et al.
Published: (2024-04-01)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
by: De‐feng Li, et al.
Published: (2023-05-01)

Virus Infection and mRNA Nuclear Export
by: Jiayin Guo, et al.
Published: (2023-08-01)

Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
by: K. Swetha, et al.
Published: (2023-03-01)

Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA
by: Eva Schrom, et al.
Published: (2017-06-01)

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
by: Gonna Somu Naidu, et al.
Published: (2023-07-01)

Modeling the effect of rRNA-mRNA interactions and mRNA folding on mRNA translation in chloroplasts
by: Stav Carmel Ezra, et al.
Published: (2022-01-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
by: Karuna M. Das, et al.
Published: (2022-04-01)

mRNA vaccines: A novel weapon to control infectious diseases
by: Yuying Tian, et al.
Published: (2022-10-01)

Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation
by: Kexin Geng, et al.
Published: (2023-11-01)

A Comprehensive Review of mRNA Vaccines
by: Vrinda Gote, et al.
Published: (2023-01-01)